APA (7th ed.) Citation

Audebrand, A., Brogi, S., Tezeren, M., Tafi, A., Ocak, O. H., Koyuncu, H., . . . Nebigil, C. G. (2026). Second‐generation prokineticin PKR1 receptor agonists: Advancing cardioprotection against chemotherapy‐induced toxicity. British Journal of Pharmacology, 183(12), 3377. https://doi.org/10.1111/bph.70394

Chicago Style (17th ed.) Citation

Audebrand, Anais, Simone Brogi, Mustafa Tezeren, Andrea Tafi, Omer H. Ocak, Hasan Koyuncu, Igor Tetko, Laurent Désaubry, and Canan G. Nebigil. "Second‐generation Prokineticin PKR1 Receptor Agonists: Advancing Cardioprotection Against Chemotherapy‐induced Toxicity." British Journal of Pharmacology 183, no. 12 (2026): 3377. https://doi.org/10.1111/bph.70394.

MLA (9th ed.) Citation

Audebrand, Anais, et al. "Second‐generation Prokineticin PKR1 Receptor Agonists: Advancing Cardioprotection Against Chemotherapy‐induced Toxicity." British Journal of Pharmacology, vol. 183, no. 12, 2026, p. 3377, https://doi.org/10.1111/bph.70394.